MedPath

Head Position After Endovascular Therapy

Not Applicable
Recruiting
Conditions
Stroke, Acute
Endovascular Therapy
Interventions
Other: The lying flat (0°-10°) head position for 72 hours
Other: The The head elevation (30°-40°) position for 72 hours
Registration Number
NCT06115707
Lead Sponsor
Zhengzhou Yuan
Brief Summary

The aim of this trial is to investigate whether head elevation position after endovascular treatment can improve the 90-day functional outcome of acute large vessel occlusion in the anterior circulation.

Detailed Description

The optimal head position for patients with acute ischemic stroke (AIS) remains uncertain. The HeadPoS study revealed that there is no significant difference in disability outcomes between patients who are placed in a lying-flat position for 24 hours and those who are placed in a sitting-up position with the head elevated to at least 30 degrees for 24 hours. However, this study included both patients with ischemic and hemorrhagic strokes, and most of the patients had mild strokes (median National Institutes of Health Stroke Scale score of 4). It is unclear how to arrange the patient's head position after endovascular treatment.

The hypothesis of this trial: Compared with the lying flat head positioni, the head elevation position after endovascular treatment can significantly improve the 90-day functional outcome of acute large vessel occlusion in the anterior circulation.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1332
Inclusion Criteria
  1. Clinical signs consistent with acute ischemic stroke;
  2. Age ≥ 18 years old;
  3. Proved anterior circulation large vessel occlusion on digital subtraction angiography (ICA, M1, M2) with/without cervical lesion (tandem);
  4. NIHSS score ≥ 8 points before endovascular treatment;
  5. ASPECTS score ≤ 7 points before endovascular treatment;
  6. Successful vessel recanalization after endovascular treatment (defined as an eTICI score of 2b, 2c, or 3) ;
  7. The time from onset to randomization ≤ 24 hours (the onset time is defined as the last normal time);
  8. Written informed consent is obtained from patients and/or their legal representatives.
Exclusion Criteria
  1. Pre-stroke mRS score>1 point;
  2. Patients with acute occlusions in multiple vascular territories (e.g. bilateral anterior circulation, or anterior/posterior circulation);
  3. Currently in pregnant or lactating or serum beta HCG test is positive on admission;
  4. Contraindications to a flat head position;
  5. Any terminal illness with life expectancy less than 6 months;
  6. Participating in other clinical trials;
  7. Patients with a preexisting neurological or psychiatric disease that would confound the neurological functional evaluations;
  8. Unlikely to be available for 90-day follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
The lying flat groupThe lying flat (0°-10°) head position for 72 hoursPatients in lying flat intervention to be nursed lying flat (0°-10°) after endovascular therapy is made and to remain in this position for 72 hours.
The head elevation groupThe The head elevation (30°-40°) position for 72 hoursPatients in the sitting up intervention should be nursed with their head elevated (30°-40°) by raising the head of the bed (or using extra pillows or wedges) after undergoing endovascular therapy, and to remain in this position for 72 hours.
Primary Outcome Measures
NameTimeMethod
Modified Rankin scale score (mRS)90 days

disability level. The presence of impairments determines the transitions from mRS score 0 to mRS score 1 (symptoms) and mRS score 5 to mRS score 6 (death).

Secondary Outcome Measures
NameTimeMethod
Health-related quality of life, assessed with the EuroQol-visual analogue scales (EQ-VAS)90 days

Health-related quality of life

Symptomatic intracerebral hemorrhage incidence (Heidelberg Criteria)within 72 hours after randomized

evaluate intracranial hemorrhage

Mortality within 90 days90 days

evaluate death rate of the two treatment groups

Proportion of patients non-disabled (mRS score 0 to 1) or return to pre-morbid mRS score at 90 days (for patients with mRS > 1)90 days

excellent outcome

Proportion of patients ambulatory or bodily needs-capable or better (mRS score 0 to 3)90 days

ambulatory or bodily needs-capable or better

severe adverse eventswithin 90 days

evaluate complications and any adverse events

Incidence of pulmonary infectionswithin 72 hours after randomized

evaluate pulmonary infections

Proportion of patients functionally independent (mRS score 0 to 2) at 90 daysWithin 90 days90 days

functional independence

Brain edemawithin 72 hours after randomized

evaluate brain edema

Any type of intracerebral hemorrhage (Heidelberg Criteria)within 72 hours after randomized

evaluate intracranial hemorrhage

Malignant Brain Edemawithin 72 hours after randomized

evaluate brain edema

Improvement in National Institute of Health stroke scale (NIHSS) score between baseline and 5~7dat 5~7 days after randomization

neurological changes.

Trial Locations

Locations (67)

Guangdong Provincial People's Hospital Heyuan Hospital

🇨🇳

Heyuan, Guangdong, China

The First People's Hospital of Chenzhou City

🇨🇳

Chenzhou, Hunan, China

The First Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

Rizhao Traditional Chinese Medicine Hospital

🇨🇳

Rizhao, Shandong, China

Chongqing Banan District People's Hospital

🇨🇳

Chongqing, Chongqing, China

Chongqing Bishan District People's Hospital

🇨🇳

Chongqing, Chongqing, China

Chongqing Ninth People's Hospital

🇨🇳

Chongqing, Chongqing, China

Yongchuan Hospital Affiliated to Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

The First Affiliated Hospital of Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

Longyan First Hospital

🇨🇳

Longyan, Fujian, China

Dingxi People's Hospital

🇨🇳

Dingxi, Gansu, China

Jiuquan People's Hospital

🇨🇳

Jiuquan, Gansu, China

Gansu Provincial Hospital of Traditional Chinese Medicine

🇨🇳

Lanzhou, Gansu, China

Lanzhou University First Hospital

🇨🇳

Lanzhou, Gansu, China

Lanzhou University Second Hospital

🇨🇳

Lanzhou, Gansu, China

Tianshui First People's Hospital

🇨🇳

Tianshui, Gansu, China

Zhujiang Hospital of Southern Medical University

🇨🇳

Guanzhou, Guangdong, China

Baise People's Hospital

🇨🇳

Baise, Guangxi, China

Nanning Third People's Hospital

🇨🇳

Nanning, Guangxi, China

Qiannan Prefecture People's Hospital

🇨🇳

Dujun, Guizhou, China

Xingyi People's Hospital

🇨🇳

Xingyi, Guizhou, China

The First Affiliated Hospital of Hainan Medical College

🇨🇳

Haikou, Hainan, China

Jiamusi Central Hospital

🇨🇳

Jiamusi, Heilongjiang, China

Yichun First Hospital

🇨🇳

Yichun, Heilongjiang, China

Anyang People's Hospital

🇨🇳

Anyang, Henan, China

Xihua County People's Hospital

🇨🇳

Zhoukou, Henan, China

Shiyan taihe hospital

🇨🇳

Shiyan, Hubei, China

Ningxiang First People's Hospital

🇨🇳

Changsha, Hunan, China

Ganzhou Municipal Hospital

🇨🇳

GanZhou, Jiangxi, China

Ganzhou People's Hospital

🇨🇳

Ganzhou, Jiangxi, China

Xingguo County People's Hospital

🇨🇳

Ganzhou, Jiangxi, China

Jiangxi Provincial People's Hospital

🇨🇳

Nanchang, Jiangxi, China

Dalian 967 Hospital

🇨🇳

Dalian, Liaoning, China

Ningxia Hui Autonomous Region People's Hospital

🇨🇳

Yinchuan, Ningxia, China

The Fifth People's Hospital of Qinghai Province

🇨🇳

Xining, Qinghai, China

Baoji High tech Hospital

🇨🇳

Baoji, Shaanxi, China

Northwest University Affiliated Hospital

🇨🇳

Xi'an, Shaanxi, China

Xianyang First People's Hospital

🇨🇳

Xianyang, Shaanxi, China

Yulin First Hospital

🇨🇳

Yulin, Shaanxi, China

Shanxi Provincial Hospital

🇨🇳

Taiyuan, Shanxi, China

Xidian Group Hospital

🇨🇳

Xi'an, Shanxi, China

Chengdu Sixth People's Hospital

🇨🇳

Chengdu, Sichuan, China

Chongzhou People's Hospital

🇨🇳

Chengdu, Sichuan, China

Deyang People's Hospital

🇨🇳

Deyang, Sichuan, China

Guangyuan First People's Hospital

🇨🇳

Guangyuan, Sichuan, China

Affiliated Hospital of Southwest Medical University

🇨🇳

Luzhou, Sichuan, China

Gulin County People's Hospital

🇨🇳

Luzhou, Sichuan, China

Beichuan County People's Hospital

🇨🇳

Mianyang, Sichuan, China

Mianyang 404 Hospital

🇨🇳

Mianyang, Sichuan, China

Mianyang Central Hospital

🇨🇳

Mianyang, Sichuan, China

Affiliated Hospital of North Sichuan Medical College

🇨🇳

Nanchong, Sichuan, China

Neijiang Second People's Hospital

🇨🇳

Neijiang, Sichuan, China

Suining Central Hospital

🇨🇳

Suining, Sichuan, China

Suining First People's Hospital

🇨🇳

Suining, Sichuan, China

Liangshan First People's Hospital

🇨🇳

Xichang, Sichuan, China

Xichang People's Hospital

🇨🇳

Xichang, Sichuan, China

Ya'an People's Hospital

🇨🇳

Ya'an, Sichuan, China

Yibin Second People's Hospital

🇨🇳

Yibin, Sichuan, China

Fushun County People's Hospital

🇨🇳

Zigong, Sichuan, China

Zigong First People's Hospital

🇨🇳

Zigong, Sichuan, China

Zigong Fourth People's Hospital

🇨🇳

Zigong, Sichuan, China

Zigong Third People's Hospital

🇨🇳

Zigong, Sichuan, China

The Seventh Affiliated Hospital of Xinjiang Medical University

🇨🇳

Ürümqi, Xinjiang, China

The First Affiliated Hospital of Kunming Medical University

🇨🇳

Kunming, Yunnan, China

The Second Affiliated Hospital of Kunming Medical University

🇨🇳

Kunming, Yunnan, China

Qujing First People's Hospital

🇨🇳

Qujing, Yunnan, China

Wenzhou Medical University First Affiliated Hospital

🇨🇳

Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath